← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 CRISPR Therapeutics CRSP $4.86B	–	–	–	–
52	52 DELISTED CATALENT, INC. CTLT	–	–	–	–
53	CYAD 53 DELISTED Celyad Oncology SA American Depositary Shares CYAD	–	–	–	–
54	DBTX 54 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
55	55 Precision BioSciences DTIL $166M	–	–	–	–
56	56 enGene Therapeutics ENGN $105M	–	–	–	–
57	57 Enlivex Ltd ENLV $4.29M	–	–	–	–
58	58 Estrella Immunopharma ESLA $13.8M	–	–	–	–
59	59 FibroBiologics FBLG $6.73M	–	–	–	–
60	60 4D Molecular Therapeutics FDMT $674M	–	–	–	–
61	FRLN 61 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
62	62 DELISTED Generation Bio GBIO	–	–	–	–
63	63 CytoMed Therapeutics GDTC $10.3M	–	–	–	–
64	GMDA 64 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
65	65 Genprex GNPX $1.91M	–	–	–	–
66	66 Genenta Science GNTA $31.8M	–	–	–	–
67	GRCL 67 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
68	GRML 68 Greenland Mines Ltd GRML $86.6M	–	–	–	–
69	69 Fractyl Health GUTS $54.1M	–	–	–	–
70	70 Immix Biopharma IMMX $706M	–	–	–	–
71	71 Immatics IMTX $1.07B	–	–	–	–
72	72 IN8bio INAB $11.8M	–	–	–	–
73	73 MiNK Therapeutics INKT $52.8M	–	–	–	–
74	74 INmune Bio INMB $44.4M	–	–	–	–
75	75 Century Therapeutics IPSC $250M	–	–	–	–